|

Intensive chemotherapy with 7 + 3 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Sumitomo Pharma America, Inc.1

Indications

  • Leukemia, Lymphocytic, Acute1
  • Leukemia, Myeloid, Acute1
  • Myelodysplastic Syndromes1
  • Multiple Myeloma1
  • Cancer1

Newport Beach, California1 trial

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Hoag Family Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.